This book was written for those who need to know how to collect, analyze and present data. It is meant to be a first course for practitioners, a book for private study or brush-up on statistics, and supplementary reading for general statistics classes. The book is untraditional, both with respect to the choice of topics and the presentation: Topics were determined by what is most useful for practical statistical work, and the presentation is as non-mathematical as possible. The book contains many examples using statistical functions in spreadsheets. In this second edition, new topics have been included e.g. within the area of statistical quality control, in order to make the book even more useful for practitioners working in industry.
This book was written for those who need to know how to collect, analyze and present data. It is meant to be a first course for practitioners, a book for private study or brush-up on statistics, and supplementary reading for general statistics classes. The book is untraditional, both with respect to the choice of topics and the presentation. The topics were determined by what is most useful for practical statistical work: even experienced statisticians will find new topics or new approaches to traditional topics. The presentation is as non-mathematical as possible. Mathematical formulae are presented only if they are necessary for calculations and/or add to readers’ understanding. A sample survey is developed as a realistic example throughout the book, and many further examples are presented, which also use data spreadsheets from a supplementary website.
Statistical Thinking for Non-Statisticians in Drug Regulation, Second Edition, is a need-to-know guide to understanding statistical methodology, statistical data and results within drug development and clinical trials. It provides non-statisticians working in the pharmaceutical and medical device industries with an accessible introduction to the knowledge they need when working with statistical information and communicating with statisticians. It covers the statistical aspects of design, conduct, analysis and presentation of data from clinical trials in drug regulation and improves the ability to read, understand and critically appraise statistical methodology in papers and reports. As such, it is directly concerned with the day-to-day practice and the regulatory requirements of drug development and clinical trials. Fully conversant with current regulatory requirements, this second edition includes five new chapters covering Bayesian statistics, adaptive designs, observational studies, methods for safety analysis and monitoring and statistics for diagnosis. Authored by a respected lecturer and consultant to the pharmaceutical industry, Statistical Thinking for Non-Statisticians in Drug Regulation is an ideal guide for physicians, clinical research scientists, managers and associates, data managers, medical writers, regulatory personnel and for all non-statisticians working and learning within the pharmaceutical industry.
This textbook will help graduate students in non-statistics disciplines, advanced undergraduate researchers, and research faculty in the health sciences to learn, use and communicate results from many commonly used statistical methods. The material covered, and the manner in which it is presented, describe the entire data analysis process from hypothesis generation to writing the results in a manuscript. Chapters cover, among other topics: one and two-sample proportions, multi-category data, one and two-sample means, analysis of variance, and regression. Throughout the text, the authors explain statistical procedures and concepts using a non-statistical language. This accessible approach is complete with real-world examples and sample write-ups for the Methods and Results sections of scholarly papers. The text also allows for the concurrent use of the programming language R, which is an open-source program created, maintained and updated by the statistical community. R is freely available and easy to download.
Examine and solve the common misconceptions and fallacies that non-statisticians bring to their interpretation of statistical results. Explore the many pitfalls that non-statisticians—and also statisticians who present statistical reports to non-statisticians—must avoid if statistical results are to be correctly used for evidence-based business decision making. Victoria Cox, senior statistician at the United Kingdom’s Defence Science and Technology Laboratory (Dstl), distills the lessons of her long experience presenting the actionable results of complex statistical studies to users of widely varying statistical sophistication across many disciplines: from scientists, engineers, analysts, and information technologists to executives, military personnel, project managers, and officials across UK government departments, industry, academia, and international partners. The author shows how faulty statistical reasoning often undermines the utility of statistical results even among those with advanced technical training. Translating Statistics teaches statistically naive readers enough about statistical questions, methods, models, assumptions, and statements that they will be able to extract the practical message from statistical reports and better constrain what conclusions cannot be made from the results. To non-statisticians with some statistical training, this book offers brush-ups, reminders, and tips for the proper use of statistics and solutions to common errors. To fellow statisticians, the author demonstrates how to present statistical output to non-statisticians to ensure that the statistical results are correctly understood and properly applied to real-world tasks and decisions. The book avoids algebra and proofs, but it does supply code written in R for those readers who are motivated to work out examples. Pointing along the way to instructive examples of statistics gone awry, Translating Statistics walks readers through the typical course of a statistical study, progressing from the experimental design stage through the data collection process, exploratory data analysis, descriptive statistics, uncertainty, hypothesis testing, statistical modelling and multivariate methods, to graphs suitable for final presentation. The steady focus throughout the book is on how to turn the mathematical artefacts and specialist jargon that are second nature to statisticians into plain English for corporate customers and stakeholders. The final chapter neatly summarizes the book’s lessons and insights for accurately communicating statistical reports to the non-statisticians who commission and act on them. What You'll Learn Recognize and avoid common errors and misconceptions that cause statistical studies to be misinterpreted and misused by non-statisticians in organizational settings Gain a practical understanding of the methods, processes, capabilities, and caveats of statistical studies to improve the application of statistical data to business decisions See how to code statistical solutions in R Who This Book Is For Non-statisticians—including both those with and without an introductory statistics course under their belts—who consume statistical reports in organizational settings, and statisticians who seek guidance for reporting statistical studies to non-statisticians in ways that will be accurately understood and will inform sound business and technical decisions
A Non-statisticians Guide to Thinking, Designing, and Executing
Author: Joseph Tal
Publisher: Academic Press
Strategy and Statistics in Clinical Trials is for all individuals engaged in clinical research, including professors, physicians, researchers in corporate and government laboratories, nurses, members of the allied health professions, and post-doctoral and graduate students who are potentially less exposed to understanding the pivotal role of statistics. . Enables nonstatisticians to better understand research processes and statistics' role in these processes . Offers real-life case studies and provides a practical, "how to" guide to biomedical R&D . Delineates the statistical building blocks and concepts of clinical trials . Promotes effective cooperation between statisticians and important other parties.